PHARMACEUTICAL FORMULATIONS OF SUBSTITUTED PYRAZOLINE COMPOUNDS

摘要

The present invention relates to the use of substituted pyrazoline compounds characterized in that the pharmaceutical formulation is in the form selected from: An oral osmotically driven system for the release of the compound A parenteral implant A Multipore tablet A Transdermal application system A parenteral depotsystem An oral formulation using a sweet tastemasker with a natural flavour or A chewable formulation, preferably a chewing gum.